statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Is What Whales Are Betting On Eli Lilly and Co

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies...

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

FDA's advisory committee meeting on June 10, 2024, discussing Eli Lilly's donanemab for early Alzheimer's.
read more...

What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments...

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

Why Eli Lilly Stock Jumped by 4% Today...

Why Eli Lilly Stock Jumped by 4% Today

Lilly Declares Second-Quarter 2024 Dividend Lilly Declares Second-Quarter 2024 Dividend PR Newswire INDIANAPOLIS, May 6, 2024 INDIANAPOLIS, May 6, 2024 /PRNewswire/ -- The board of directors of Eli...

Lilly Declares Second-Quarter 2024 Dividend

Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making...

Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making

If Soranus of Ephesus were alive today he'd be mighty surprised.Like his modern-day counterparts in the medical field, the 2nd Century Greek physician considered obesity to be a disease, and he...

Analyst unveils Amgen stock price target after weight-loss drug data

At least 25,000 Americans are beginning treatment with Novo Nordisk's Wegovy each week and that figure is growing, the company said.The Danish pharmaceutical giant, which has been ramping up...

25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update

 Amgen's shares soared in premarket trading in New York following the drug maker's...

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Watchers	17,969
52-Wk Low	$419.80
52-Wk High	$800.78

Volume	280,925.00
52-Wk High	$800.78
52-Wk Low	$419.80

LLY Lilly(Eli) & Co

About

Feed

News

Sentiment

Earnings

Fundamentals